ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.182,63
-0,10%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,178
0,13%
Bitcoin
69.929,80
2,07%
Brent Oil
82,645
0,81%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) Notícias

IGMS

IGM Biosciences (IGMS)

IGM Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IGMS
DataHoraFonteTítuloCódigoCompanhia
08/05/202417:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
08/05/202417:10GlobeNewswire Inc.IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
08/05/202417:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IGMSIGM Biosciences Inc
07/05/202408:00GlobeNewswire Inc.IGM Biosciences to Present at the 2024 RBCCM Global Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
17/04/202409:30GlobeNewswire Inc.IGM Biosciences Announces Refocusing of Sanofi CollaborationNASDAQ:IGMSIGM Biosciences Inc
10/04/202408:00GlobeNewswire Inc.IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IGMSIGM Biosciences Inc
07/03/202418:27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IGMSIGM Biosciences Inc
07/03/202418:10GlobeNewswire Inc.IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
05/03/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
01/02/202409:00GlobeNewswire Inc.IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IGMSIGM Biosciences Inc
03/01/202409:00GlobeNewswire Inc.IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
13/12/202319:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IGMSIGM Biosciences Inc
05/12/202318:01GlobeNewswire Inc.IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway ExtensionNASDAQ:IGMSIGM Biosciences Inc
01/12/202307:32PR Newswire (US)Bulletin from Extraordinary General Meeting in Medivir AB (publ)NASDAQ:IGMSIGM Biosciences Inc
28/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IGMSIGM Biosciences Inc
21/11/202304:48PR Newswire (US)Medivir to present at the Erik Penser Bank Company EventNASDAQ:IGMSIGM Biosciences Inc
13/11/202319:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IGMSIGM Biosciences Inc
13/11/202318:10GlobeNewswire Inc.IGM Biosciences Announces Third Quarter 2023 Financial ResultsNASDAQ:IGMSIGM Biosciences Inc
07/11/202309:00GlobeNewswire Inc.IGM Biosciences to Present at Two Upcoming Investor ConferencesNASDAQ:IGMSIGM Biosciences Inc
05/10/202320:42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
05/10/202308:29PR Newswire (US)Fostrox + Lenvima continues to show promising tumor control in HCC, all patients have now dosed at least two treatment cyclesNASDAQ:IGMSIGM Biosciences Inc
03/10/202317:05GlobeNewswire Inc.IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of DirectorsNASDAQ:IGMSIGM Biosciences Inc
06/09/202308:00GlobeNewswire Inc.IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
03/08/202317:10GlobeNewswire Inc.IGM Biosciences Announces Second Quarter 2023 Financial ResultsNASDAQ:IGMSIGM Biosciences Inc
19/07/202317:13Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:IGMSIGM Biosciences Inc
07/07/202315:26Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IGMSIGM Biosciences Inc
03/07/202317:01GlobeNewswire Inc.IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:IGMSIGM Biosciences Inc
28/06/202320:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IGMSIGM Biosciences Inc
28/06/202318:15Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IGMSIGM Biosciences Inc
27/06/202318:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IGMSIGM Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IGMS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
OIBR3
OI ON
BOV
RNEW4
RENOVA PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
SGPS3
SPRINGS ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
HAGA3
HAGA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PSVM11
PORTO SUDESTE
BOV
HOOT4
HOTEIS OTHON PN
BOV
AMER3
Americanas ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
TELB4
TELEBRAS PN
BOV
ENAT3
ENAUTA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados